Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data from glioblastoma stem cells after knockdown of PUS7

ABSTRACT: Expression data from glioblastoma stem cells after knockdown of PUS7

PROVIDER: PRJNA614467 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11391677.fastq.gz	Fastqsanger.gz
	SRR11391678.fastq.gz	Fastqsanger.gz
	SRR11391679.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

Expression data from glioblastoma stem cells after knockdown of PUS7

Project description:PUS7, a pseudouridine synthase, plays a critical role in growth, self-renewal, and tumorigenesis of glioblastoma stem cells. We used RNA-seq to investigate the global gene expression regulated by PUS7 and identified downstream pathway of PUS7 in glioblastoma stem cells.

2021-06-18 | GSE147382 | GEO

Glioblastoma stem cells after METTL8 knockdown.

Project description:Glioblastoma stem cells after METTL8 knockdown.

| PRJNA788505 | ENA

Gene expression profiles in SATB2-knockdown and control human glioblastoma stem cells

Project description:Effects of SATB2 knockdown on gene expression were evaluated by microarray analysis in human glioblastoma stem cells

2020-09-12 | GSE154789 | GEO

Human PUS7 in tRNA pseudouridylation

Project description:Pseudouridine is the first discovered and the most frequent modification in RNA. However, its biological functions in physiology and human diseases are largely unknown. Here, we show that pseudouridine synthase PUS7 is differentially expressed in glioblastoma patient tissues verse non-tumor brain tissues, and highly expressed in patient brain-derived cancer stem cells, compared to normal brain-derived neural stem cells. Upregulated expression of PUS7 predicts worse survival in glioblastoma patients in multiple databases. Indeed, we show that PUS7 plays an important role in regulating the self-renewal and tumorigenesis of glioblastoma stem cells. Overexpression of the wild type but not the catalytically inactive PUS7 increases the growth and self-renewal of GSCs. In contrast, knockdown of PUS7 dramatically suppresses GSC growth, self-renewal and tumorigenesis. Mechanistically, knockdown of PUS7 activates interferon pathway through translational control of TYK2 via PUS7-regulated tRNAs. Moreover, we have identified chemical inhibitors for PUS7 in this study. These chemical compounds target pseudouridine modification and suppress GSC growth and tumorigenesis, providing a potential therapeutic tool for GBM treatment.

2021-06-18 | GSE147342 | GEO

RNA-seq of glioblastoma stem cells with shRNA-mediated CCR7 knockdown

Project description:RNA-seq of glioblastoma stem cells with shRNA-mediated CCR7 knockdown

2023-08-04 | GSE218042 | GEO

RNA-seq of YY1 knockdown and alvocidib treatment in glioblastoma stem cells

Project description:RNA-seq of YY1 knockdown and alvocidib treatment in glioblastoma stem cells

2022-06-01 | GSE155836 | GEO

Norrie Disease Protein (NDP) gene knockdown patient-derived glioblastoma stem cell lines

Project description:RNA-Seq to test differential gene expression in response to Norrie Disease Protein (NDP) gene knockdown glioblastoma stem cells.

2020-03-03 | GSE128255 | GEO

Expression data from glioblastoma stem cells

Project description:TLX (NR2E1), as an orphan nuclear receptor, plays a critical role in growth, self-renewal, and tumorigenesis of glioblastoma stem cells. We used microarrays to investigate the global gene expression regulated by TLX and identified downstream targets of TLX in glioblastoma stem cells. We further investigated the global gene expression regulated by TET3, a downstream target of TLX, to identified downstream targets of TLX-TET3 axis in glioblastoma stem cells.

2016-02-01 | GSE75945 | GEO